| Schedule of Weighted Average Shares Outstanding |
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to the shareholders of the Company: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | (in Thousands, except per share data) | June 30, 2024 | | June 30, 2023 | | June 30, 2024 | | June 30, 2023 | Numerator: | | | | | | | | Net Income (Loss) | $ | 6,561 | | | $ | (7,262) | | | $ | 2,033 | | | $ | (20,342) | | Number of shares used in per share calculation: | | | | | | | | | Common shares | 1,169,507 | | | 560,638 | | | 1,155,033 | | | 557,488 | | | Common shares issuable assuming exercise of nominally priced warrants | 13,091 | | | 21,691 | | | 17,391 | | | 21,691 | | Total shares used for calculating basic income (loss) per share | 1,182,598 | | | 582,329 | | | 1,172,424 | | | 579,179 | | Weighted-average effect of dilutive securities: | | | | | | | | Common shares issuable on convertible promissory notes including interest | 205,090 | | | — | | | 201,475 | | | — | | Total shares for purposes of calculating diluted net income (loss) per share | 1,387,688 | | | 582,329 | | | 1,373,899 | | | 579,179 | | Net income (loss) per share: | | | | | | | | | Basic | $ | 0.01 | | | $ | (0.01) | | | $ | — | | | $ | (0.04) | | | Diluted | $ | — | | | $ | (0.01) | | | $ | — | | | $ | (0.04) | |
|
| Schedule of Anti-dilutive Equity Securities |
As a result of the net loss for the six months ended June 30, 2023, all potentially dilutive shares in such periods were anti-dilutive and therefore excluded from the computation of diluted net loss per share. | | | | | | | | | | | | | Six Months Ended | (in thousands) | June 30, 2024 | | June 30, 2023 | Common stock options | 15,737 | | | 19,136 | | Common stock purchase warrants | 1,492,500 | | | 1,247,911 | | Convertible notes payable, including interest | 20,566 | | | 677,050 | | | 1,528,803 | | | 1,944,097 | |
|